Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
Journal: Nature biotechnology
Published: June 07, 2021
Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 27, 2021
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 29, 2021
An evaluation of apalutamide for the treatment of prostate cancer.
Journal: Expert opinion on pharmacotherapy
Published: June 17, 2020
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: December 13, 2019
A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 12, 2019
Systemic Treatment of Prostate Cancer in Elderly Patients: Current Role and Safety Considerations of Androgen-Targeting Strategies.
Journal: Drugs & aging
Published: June 07, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026